Definitive Healthcare Corp.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US24477E1038
USD
1.96
-0.21 (-9.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

316.45 k

Shareholding (Sep 2025)

FII

2.89%

Held by 67 FIIs

DII

24.86%

Held by 32 DIIs

Promoter

54.16%

How big is Definitive Healthcare Corp.?

22-Jun-2025

As of Jun 18, Definitive Healthcare Corp. has a market capitalization of 553.16 million, with net sales of 247.92 million and a net profit of -733.82 million over the latest four quarters. Shareholder's funds are 444.38 million, and total assets are 1,089.39 million.

As of Jun 18, Definitive Healthcare Corp. has a market capitalization of 553.16 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 247.92 million, while the sum of net profit for the same period is -733.82 million.<BR><BR>As of Dec 24, the shareholder's funds amount to 444.38 million, and the total assets are reported at 1,089.39 million.

View full answer

What does Definitive Healthcare Corp. do?

22-Jun-2025

Definitive Healthcare Corp. is a micro-cap software company with recent net sales of $59 million and a net profit of -$155 million. It has a market cap of $553.16 million, a P/E ratio of 4.00, and a return on equity of 42.45%.

Overview: <BR>Definitive Healthcare Corp. operates in the software products industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 59 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -155 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 553.16 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 4.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.08 <BR>Return on Equity: 42.45% <BR>Price to Book: 1.71<BR><BR>Contact Details: <BR>Registrar Address: Not available.

View full answer

Should I buy, sell or hold Definitive Healthcare Corp.?

22-Jun-2025

Is Definitive Healthcare Corp. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, Definitive Healthcare Corp. shows a mildly bullish trend with positive short-term momentum, but significant long-term underperformance compared to the S&P 500.

As of 2 September 2025, the technical trend for Definitive Healthcare Corp. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the KST shows a mildly bearish stance on the weekly and bearish on the monthly, suggesting caution. The daily moving averages are bullish, supporting a short-term positive outlook. <BR><BR>In terms of returns, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.63% and 8.91% respectively, compared to the S&P 500's 1.05% and 2.33%. However, over the longer term, the stock has underperformed significantly, with a 1-year return of -6.14% versus the S&P 500's 17.14%, and a staggering -76.57% over the past 3 years compared to the S&P's 70.41%. Overall, the current stance is mildly bullish, but with notable weaknesses in longer-term performance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor Management Efficiency with a low ROE of 8.92%

  • The company has been able to generate a Return on Equity (avg) of 8.92% signifying low profitability per unit of shareholders funds
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Software Products

stock-summary
Market cap

USD 246 Million (Micro Cap)

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

6.08%

stock-summary
Price to Book

0.86

Revenue and Profits:
Net Sales:
61 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-29.5%
0%
-29.5%
6 Months
-48.96%
0%
-48.96%
1 Year
-61.94%
0%
-61.94%
2 Years
-77.24%
0%
-77.24%
3 Years
-85.06%
0%
-85.06%
4 Years
-91.39%
0%
-91.39%
5 Years
0%
0%
0.0%

Definitive Healthcare Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
19.99%
EBIT Growth (5y)
-166.90%
EBIT to Interest (avg)
0.50
Debt to EBITDA (avg)
1.12
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.34
Tax Ratio
6.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.08%
ROE (avg)
8.92%

Valuation key factors

Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.70
EV to EBIT
-57.70
EV to EBITDA
11.88
EV to Capital Employed
1.76
EV to Sales
2.10
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
-3.05%
ROE (Latest)
42.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 44 Schemes (18.07%)

Foreign Institutions

Held by 67 Foreign Institutions (2.89%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -4.55% vs 4.43% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 96.96% vs -2,539.66% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60.80",
          "val2": "63.70",
          "chgp": "-4.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.80",
          "val2": "9.60",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "3.80",
          "chgp": "-21.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-366.50",
          "chgp": "99.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.30",
          "val2": "-306.20",
          "chgp": "96.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-57.60%",
          "val2": "-49.40%",
          "chgp": "-0.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.32% vs 12.89% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -104.21% vs -1,096.69% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "252.20",
          "val2": "251.40",
          "chgp": "0.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.90",
          "val2": "20.80",
          "chgp": "101.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.80",
          "val2": "15.20",
          "chgp": "-2.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-701.10",
          "val2": "-298.90",
          "chgp": "-134.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-591.40",
          "val2": "-289.60",
          "chgp": "-104.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-38.60%",
          "val2": "-122.90%",
          "chgp": "8.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary

Jun'25
Jun'24
Change(%)
Net Sales
60.80
63.70
-4.55%
Operating Profit (PBDIT) excl Other Income
10.80
9.60
12.50%
Interest
3.00
3.80
-21.05%
Exceptional Items
-0.70
-366.50
99.81%
Consolidate Net Profit
-9.30
-306.20
96.96%
Operating Profit Margin (Excl OI)
-57.60%
-49.40%
-0.82%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -4.55% vs 4.43% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 96.96% vs -2,539.66% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
252.20
251.40
0.32%
Operating Profit (PBDIT) excl Other Income
41.90
20.80
101.44%
Interest
14.80
15.20
-2.63%
Exceptional Items
-701.10
-298.90
-134.56%
Consolidate Net Profit
-591.40
-289.60
-104.21%
Operating Profit Margin (Excl OI)
-38.60%
-122.90%
8.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.32% vs 12.89% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -104.21% vs -1,096.69% in Dec 2023

stock-summaryCompany CV
About Definitive Healthcare Corp. stock-summary
stock-summary
Definitive Healthcare Corp.
Software Products
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available